Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease. (Record no. 16276311)

MARC details
000 -LEADER
fixed length control field 01408 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515024554.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200704s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0049-3848
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.thromres.2006.03.005
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Dropinski, Jerzy
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20070405
245 00 - TITLE STATEMENT
Title Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Thrombosis research
Date of publication, distribution, etc. 2007
300 ## - PHYSICAL DESCRIPTION
Extent 301-3 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Alleles
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aspirin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bleeding Time
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Coronary Artery Disease
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclooxygenase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Homozygote
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Integrin beta3
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Polymorphism, Genetic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombin Time
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Musial, Jacek
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanak, Marek
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wegrzyn, Wojciech
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Nizankowski, Rafal
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Szczeklik, Andrew
773 0# - HOST ITEM ENTRY
Title Thrombosis research
Related parts vol. 119
-- no. 3
-- p. 301-3
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.thromres.2006.03.005">https://doi.org/10.1016/j.thromres.2006.03.005</a>
Public note Available from publisher's website

No items available.